DLD Asset Management »

Voyager Therapeutics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Voyager Therapeutics (VYGR) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Voyager Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Voyager Therapeutics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Voyager Therapeutics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $70k 20k 3.50

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Marathon Digital Holdings In Put Option (MARA)
Eli Lilly & Co. Call Option (LLY)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Encore Cap Group Note 4.000% 3/1 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Super Micro Computer Com New Put Option (SMCI)
Merit Med Sys Note 3.000% 2/0 (Principal)

View all positions for DLD Asset Management

Top funds holding Voyager Therapeutics

BlackRock
Millennium Management
Armistice Capital
Vestal Point Capital
Vanguard Capital Management
Geode Capital Management
Opaleye Management
Two Sigma Investments
State Street Corporation
Citadel Advisors
Dimensional Fund Advisors
Vanguard Portfolio Management
Morgan Stanley
Erste Asset Management GmbH
Diadema Partners

View all funds holding Voyager Therapeutics